These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5725417)

  • 1. [Excretion of hormones in patients with cancer of the breast after hormone loading with testosterone-propionate].
    Olinia AIa
    Klin Lech Zlokach Novoobraz; 1968; 11():79-92. PubMed ID: 5725417
    [No Abstract]   [Full Text] [Related]  

  • 2. [Excretion of hormones in patients with cancer of the breast after hormone loading with synestrol and cortisone].
    Olinia AIa
    Klin Lech Zlokach Novoobraz; 1968; 11():93-104. PubMed ID: 5725418
    [No Abstract]   [Full Text] [Related]  

  • 3. [Some regularities of estrogen and pregnanediol excretion in patients with cancer of mammary glands].
    Kurochkin IuF
    Vrach Delo; 1968 Jan; 1():115-6. PubMed ID: 5672335
    [No Abstract]   [Full Text] [Related]  

  • 4. The study of the excretion of estrogens in patients with breast cancer treated with androgens.
    Sharoukhova KS; Muraviova NI; Kurockin IF; Vishnyakova VV
    Neoplasma; 1972; 19(4):331-4. PubMed ID: 5054533
    [No Abstract]   [Full Text] [Related]  

  • 5. Elevated urine estrogen and pregnanediol levels in daughters of breast cancer patients.
    Trichopoulos D; Brown JB; Garas J; Papaioannou A; MacMahon B
    J Natl Cancer Inst; 1981 Sep; 67(3):603-6. PubMed ID: 6944532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary oestrogens and pregnandiol in breast cancer patients.
    Zaki K; El-Kharadly M; El-Faras A; Nour H; Kamel NI
    Endokrinologie; 1982 Feb; 79(1):49-56. PubMed ID: 7084131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urinary excretion of total estrogens, pregnanediol and luteotropic hormone after administration of medroxyprogesterone acetate].
    Wesel S; Bottari P
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):336-7. PubMed ID: 4681539
    [No Abstract]   [Full Text] [Related]  

  • 8. Endocrine status and the epidemiology and clinical course of breast cancer.
    Moore JW; Thomas BS; Wang DY
    Cancer Surv; 1986; 5(3):537-59. PubMed ID: 3555782
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of breast structure and oestrogen and pregnanediol excretion in mammary cancer patiens.
    JULL JW; DOSSETT PJ; SHUCKSMITH HS; BONSER GM
    Acta Unio Int Contra Cancrum; 1959; 15():1108-13. PubMed ID: 14408140
    [No Abstract]   [Full Text] [Related]  

  • 10. Urine estrogens, frequency of ovulation, and breast cancer risk: case-control study in premenopausal women.
    MacMahon B; Cole P; Brown JB; Paffenbarger R; Trichopoulos D; Yen S
    J Natl Cancer Inst; 1983 Feb; 70(2):247-50. PubMed ID: 6571932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics.
    Dai Q; Franke AA; Yu H; Shu XO; Jin F; Hebert JR; Custer LJ; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):497-502. PubMed ID: 12814993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [17-ketosteroid changes in breast cancer during testosterone propionate treatment].
    Mindlin SS; Smiller RR
    Vopr Onkol; 1970; 16(7):17-20. PubMed ID: 5482837
    [No Abstract]   [Full Text] [Related]  

  • 13. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses.
    Santen RJ; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H
    Cancer Res; 1982 Aug; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of 0.5 mg lynestrenol on the follicle stimulating hormone, luteinizing hormone, oestrogen and pregnanediol excretion during the menstrual cycle.
    Schmidt-Elmendorff H; Kaiser E; Kopera H
    Arzneimittelforschung; 1969 Aug; 19(8):1277-9. PubMed ID: 5820293
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnostic value of the chemical determination of urinary estrogens and pregnanediol].
    Ramos F; Ruiz J; Valverde I; Vivanco F
    Minerva Med; 1968 Jul; 59(56):3150-64. PubMed ID: 4385912
    [No Abstract]   [Full Text] [Related]  

  • 16. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.
    Yu H; Shu XO; Li BD; Dai Q; Gao YT; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1067-73. PubMed ID: 14578144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormone excretion during and after treatment with Lyndiol 2.5].
    Keller M
    Gynaecologia; 1967; 163(4):187-98. PubMed ID: 6029674
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the endocrinology of hirsutism in women.
    Ismail AA; Davidson DW; Kirkham KE; Loraine JA
    J Endocrinol; 1969 Jan; 43(1):28. PubMed ID: 5789221
    [No Abstract]   [Full Text] [Related]  

  • 19. [The excretion of classical estrogens and total phenolsteroids in patients with uterine cancer].
    Bershteĭn LM
    Vopr Onkol; 1967; 13(9):48-52. PubMed ID: 5599604
    [No Abstract]   [Full Text] [Related]  

  • 20. [Excretion of steroid hormones in women with luteal insufficiency].
    Vrtílek V; Drác P
    Cesk Gynekol; 1966 Aug; 31(6):504-7. PubMed ID: 5925819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.